Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.00529100529100518 0.00881834215167545 -0.0044091710758378
Stock impact report

Dermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference

Journey Medical Corporation (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com
Company Research Source: Business Wire
- Detailed primary results of lebrikizumab Phase 2b study to be presented at the Fall Clinical Dermatology Conference- Data reflect potential of lebrikizumab to offer best-in-disease combination of safety, efficacy, tolerability, convenience and ease of use- Conference call and webcast to be held on October 17 to discuss data and provide overview of Phase 3 clinical development program MENLO PARK, Calif.--(BUSINESS WIRE)--Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that detailed primary results of its Phase 2b study of lebrikizumab in patients with moderate-to-severe atopic dermatitis will be reported at the 39th Annual Fall Clinical Dermatology Conference in Las Vegas, NV, October 17-20, 2019. In addition, the company will host a conference call and webcast on October 17, 2019, duri Show less Read more
Impact Snapshot
Event Time:
DERM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for DERM alerts
Opt-in for
DERM alerts

from News Quantified
Opt-in for
DERM alerts

from News Quantified